Chordate Medical Holding AB (publ) (CMH.ST)
SEK 12.6
(-1.18%)
SEK 12.6
(-1.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 976.28 Thousand SEK | 799.66% |
| 2022 | 108.51 Thousand SEK | -87.7% |
| 2021 | 882.04 Thousand SEK | 42.72% |
| 2020 | 618 Thousand SEK | -46.89% |
| 2019 | 1.16 Million SEK | 23.13% |
| 2018 | 945.11 Thousand SEK | -5.04% |
| 2017 | 995.32 Thousand SEK | 499.91% |
| 2016 | 165.91 Thousand SEK | -74.28% |
| 2015 | 645.14 Thousand SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 257.67 Thousand SEK | -46.5% |
| 2024 Q2 | 172.94 Thousand SEK | -32.88% |
| 2023 Q4 | 481.59 Thousand SEK | 128.3% |
| 2023 Q1 | 120.42 Thousand SEK | 491.84% |
| 2023 Q3 | 210.94 Thousand SEK | 29.16% |
| 2023 Q2 | 163.31 Thousand SEK | 35.62% |
| 2023 FY | 976.28 Thousand SEK | 799.66% |
| 2022 Q1 | 68.63 Thousand SEK | -82.98% |
| 2022 FY | 108.51 Thousand SEK | -87.7% |
| 2022 Q4 | 20.34 Thousand SEK | 0.0% |
| 2022 Q3 | - SEK | -100.0% |
| 2022 Q2 | 19.53 Thousand SEK | -71.53% |
| 2021 FY | 882.04 Thousand SEK | 42.72% |
| 2021 Q1 | 101.62 Thousand SEK | 25.47% |
| 2021 Q2 | 165.69 Thousand SEK | 63.05% |
| 2021 Q3 | 211.46 Thousand SEK | 27.62% |
| 2021 Q4 | 403.25 Thousand SEK | 90.7% |
| 2020 Q1 | 463.16 Thousand SEK | 48.83% |
| 2020 Q4 | 80.99 Thousand SEK | 320.42% |
| 2020 FY | 618 Thousand SEK | -46.89% |
| 2020 Q3 | 19.26 Thousand SEK | -64.7% |
| 2020 Q2 | 54.57 Thousand SEK | -88.22% |
| 2019 FY | 1.16 Million SEK | 23.13% |
| 2019 Q1 | 58.47 Thousand SEK | -17.88% |
| 2019 Q2 | 398.95 Thousand SEK | 582.32% |
| 2019 Q3 | 395.1 Thousand SEK | -0.96% |
| 2019 Q4 | 311.19 Thousand SEK | -21.24% |
| 2018 Q3 | 51.31 Thousand SEK | -89.27% |
| 2018 FY | 945.11 Thousand SEK | -5.04% |
| 2018 Q2 | 478.22 Thousand SEK | 146.04% |
| 2018 Q1 | 194.36 Thousand SEK | 310.7% |
| 2018 Q4 | 71.2 Thousand SEK | 38.76% |
| 2017 Q1 | 272.58 Thousand SEK | 1282.84% |
| 2017 FY | 995.32 Thousand SEK | 499.91% |
| 2017 Q2 | 500.48 Thousand SEK | 83.61% |
| 2017 Q3 | 174.92 Thousand SEK | -65.05% |
| 2017 Q4 | 47.32 Thousand SEK | -72.95% |
| 2016 Q3 | 144.2 Thousand SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 FY | 165.91 Thousand SEK | -74.28% |
| 2016 Q4 | 19.71 Thousand SEK | -86.33% |
| 2015 FY | 645.14 Thousand SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | 84.357% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 99.929% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 99.929% |
| Arcoma AB | 163.01 Million SEK | 99.401% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | 99.521% |
| BICO Group AB (publ) | 2.23 Billion SEK | 99.956% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | 99.829% |
| CellaVision AB (publ) | 677.29 Million SEK | 99.856% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | 88.199% |
| C-Rad AB (publ) | 424.61 Million SEK | 99.77% |
| Duearity AB (publ) | 1.65 Million SEK | 40.975% |
| Dignitana AB (publ) | 86.06 Million SEK | 98.866% |
| Episurf Medical AB (publ) | 10.3 Million SEK | 90.522% |
| Getinge AB (publ) | 31.82 Billion SEK | 99.997% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | 86.207% |
| Integrum AB (publ) | 104.11 Million SEK | 99.062% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -14.225% |
| Mentice AB (publ) | 273.61 Million SEK | 99.643% |
| OssDsign AB (publ) | 112.15 Million SEK | 99.13% |
| Paxman AB (publ) | 210.11 Million SEK | 99.535% |
| Promimic AB (publ) | 37.07 Million SEK | 97.366% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -300.115% |
| SciBase Holding AB (publ) | 23.24 Million SEK | 95.8% |
| ScandiDos AB (publ) | 60.42 Million SEK | 98.384% |
| Sectra AB (publ) | 2.96 Billion SEK | 99.967% |
| Sedana Medical AB (publ) | 153.86 Million SEK | 99.366% |
| Senzime AB (publ) | 35.75 Million SEK | 97.269% |
| SpectraCure AB (publ) | 318 Thousand SEK | -207.007% |
| Stille AB | 294.89 Million SEK | 99.669% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 99.972% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | 99.837% |